Araki et al. studied the connection between TDP-43 and glucose intolerance and noticed that patients with ALS presented decreased early-phase insulin secretion as well as the loss of nuclear localization of TDP-43 at the level of the islet pancreatic cells. Here, INS is linked to Glucose intolerance.